Author | Jessica K. Altman, MD | OncLive

Author | Jessica K. Altman, MD

Articles

Dr. Altman on Gilteritinib in Patients With Relapsed/Refractory AML

August 23, 2017

Video

Jessica K. Altman, MD, associate professor of medicine (hematology and oncology), Feinberg School of Medicine, Northwestern Medicine, discusses an early-phase study of gilteritinib in FLT3-mutation–positive patients with acute myeloid leukemia (AML).

x